胆囊癌的现行治疗方法。
Current management of gallbladder carcinoma.
机构信息
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA.
出版信息
Oncologist. 2010;15(2):168-81. doi: 10.1634/theoncologist.2009-0302. Epub 2010 Feb 10.
Abstract
Gallbladder cancer (GBC) represents the most common and aggressive type among the biliary tree cancers (BTCs). Complete surgical resection offers the only chance for cure; however, only 10% of patients with GBC present with early-stage disease and are considered surgical candidates. Among those patients who do undergo "curative" resection, recurrence rates are high. There are no established adjuvant treatments in this setting. Patients with unresectable or metastatic GBC have a poor prognosis. There has been a paucity of randomized phase III data in this field. A recent report demonstrated longer overall survival with gemcitabine in combination with cisplatin than with gemcitabine alone in patients with advanced or metastatic BTCs. Molecularly targeted agents are under development. In this review, we attempt to discuss the current status and key issues involved in the management of GBC.
摘要
胆囊癌 (GBC) 是胆道系统癌症 (BTCs) 中最常见且侵袭性最强的类型。彻底的手术切除是唯一的治愈机会；然而，只有 10%的 GBC 患者在早期出现并被认为是手术候选者。在那些接受“治愈性”切除的患者中，复发率很高。在这种情况下，尚无既定的辅助治疗方法。不可切除或转移性 GBC 患者预后较差。在这一领域，缺乏随机 III 期数据。最近的一份报告表明，与单独使用吉西他滨相比，在晚期或转移性 BTCs 患者中，吉西他滨联合顺铂可延长总体生存期。分子靶向药物正在开发中。在这篇综述中，我们试图讨论 GBC 管理中涉及的当前状况和关键问题。
相似文献
1
Current management of gallbladder carcinoma.胆囊癌的现行治疗方法。
Oncologist. 2010;15(2):168-81. doi: 10.1634/theoncologist.2009-0302. Epub 2010 Feb 10.
2
Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward.吉西他滨-顺铂（GC）作为可切除 II 期和 III 期胆囊癌（GBC）的辅助化疗：一种潜在的前进方向。
Med Oncol. 2018 Mar 21;35(4):57. doi: 10.1007/s12032-018-1115-6.
3
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.手术及辅助治疗在胆囊和肝内胆管淋巴结阳性癌症中的作用。
Cancer. 2018 Jan 1;124(1):74-83. doi: 10.1002/cncr.30968. Epub 2017 Aug 25.
4
[Chemotherapy in gallbladder carcinoma].[胆囊癌的化疗]
Presse Med. 2010 Dec;39(12):1238-45. doi: 10.1016/j.lpm.2010.09.002. Epub 2010 Nov 11.
5
Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.辅助性外照射放疗联合化疗在胆囊癌治疗中的应用
Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):167-75. doi: 10.1016/s0360-3016(01)01764-3.
6
Updates on Gallbladder Cancer Management.胆囊癌管理的最新进展。
Curr Oncol Rep. 2018 Mar 2;20(2):21. doi: 10.1007/s11912-018-0664-3.
7
Gallbladder cancer, treatment failure and relapses: the peritoneum in gallbladder cancer.胆囊癌、治疗失败与复发：胆囊癌中的腹膜
J Gastrointest Cancer. 2014 Sep;45(3):245-55. doi: 10.1007/s12029-014-9597-8.
8
Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India.印度北部一家三级肿瘤学中心的经验：胆囊癌的多模态管理可带来更好的结果。
World J Gastroenterol. 2021 Dec 7;27(45):7813-7830. doi: 10.3748/wjg.v27.i45.7813.
9
The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review.新辅助化疗或放化疗在晚期胆囊癌治疗中的作用——系统评价。
Eur J Surg Oncol. 2019 Feb;45(2):83-91. doi: 10.1016/j.ejso.2018.08.020. Epub 2018 Sep 7.
10
Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.基于贝叶斯网络预测模型估算可切除的晚期胆囊腺癌辅助治疗的生存获益。
World J Gastroenterol. 2019 Oct 7;25(37):5655-5666. doi: 10.3748/wjg.v25.i37.5655.
引用本文的文献
1
Gallbladder Cancer and Peritoneal Metastasis: Is there any role of Cytoreductive Surgery (CRS) and/or Hyperthermic Intraperitoneal Chemotherapy (HIPEC)? A Narrative Review.胆囊癌与腹膜转移：细胞减灭术（CRS）和/或腹腔内热化疗（HIPEC）是否有作用？一篇叙述性综述。
J Gastrointest Cancer. 2025 Aug 6;56(1):169. doi: 10.1007/s12029-025-01294-w.
2
Recurrent DVT and Mediastinal Adenopathy: A Silent Manifestation of Gallbladder Cancer.复发性深静脉血栓形成与纵隔淋巴结肿大：胆囊癌的一种隐匿表现
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251340739. doi: 10.1177/23247096251340739. Epub 2025 May 21.
3
Quantitative MRCP metrics as imaging biomarkers to differentiate benign from malignant bile duct obstructions.作为成像生物标志物的定量磁共振胰胆管造影（MRCP）指标用于鉴别良性与恶性胆管梗阻。
Front Oncol. 2025 May 6;15:1576163. doi: 10.3389/fonc.2025.1576163. eCollection 2025.
4
Hotspots and scientometrics in gallbladder cancer surgery research: a bibliometric and visualization analysis (2014-2024).胆囊癌手术研究中的热点与科学计量学：文献计量与可视化分析（2014 - 2024）
Front Oncol. 2025 Apr 3;15:1522992. doi: 10.3389/fonc.2025.1522992. eCollection 2025.
5
Epidermal Growth Factor Receptor (EGFR) and SMAD4 negatively correlated in the progression of gallbladder cancer in Eastern Indian patients.在东印度患者的胆囊癌进展过程中，表皮生长因子受体（EGFR）与SMAD4呈负相关。
BMC Gastroenterol. 2024 Dec 3;24(1):446. doi: 10.1186/s12876-024-03485-4.
6
The usefulness of B-cell lymphoma-2 immunohistochemical stain in the differentiation between reactive atypia and dysplasia/carcinoma in the gallbladder.B细胞淋巴瘤-2免疫组化染色在胆囊反应性异型增生与发育异常/癌鉴别诊断中的应用价值。
Int J Health Sci (Qassim). 2024 Nov-Dec;18(6):20-24.
7
A Single-Center Analysis of Patient Characteristics and Overall Survival in Patients with Resectable Gallbladder Cancer.可切除胆囊癌患者的患者特征及总生存的单中心分析
Healthcare (Basel). 2024 Oct 21;12(20):2091. doi: 10.3390/healthcare12202091.
8
Gallbladder cancer: Progress in the Indian subcontinent.胆囊癌：印度次大陆的研究进展
World J Clin Oncol. 2024 Jun 24;15(6):695-716. doi: 10.5306/wjco.v15.i6.695.
9
Prognostic Insights and Survival Analysis of Gallbladder Cancer in Bihar, India: a Prospective Observational Study Emphasizing the Impact of Surgical Intervention on Overall Survival.印度比哈尔邦胆囊癌的预后洞察与生存分析：一项强调手术干预对总生存影响的前瞻性观察研究
Indian J Surg Oncol. 2024 May;15(Suppl 2):196-203. doi: 10.1007/s13193-024-01925-x. Epub 2024 Mar 18.
10
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy and intraoperative radiation therapy in the management of gallbladder cancer: a case report.细胞减灭术联合腹腔内热化疗及术中放射治疗在胆囊癌治疗中的应用：1例病例报告
Front Oncol. 2024 Apr 3;14:1361017. doi: 10.3389/fonc.2024.1361017. eCollection 2024.
本文引用的文献
1
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.吉西他滨、奥沙利铂和贝伐珠单抗治疗晚期胆道癌的疗效和安全性，以及 18-氟脱氧葡萄糖 PET 变化与临床结局的相关性：一项 2 期研究。
Lancet Oncol. 2010 Jan;11(1):48-54. doi: 10.1016/S1470-2045(09)70333-X. Epub 2009 Nov 20.
2
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.美国国立综合癌症网络（NCCN）肿瘤学临床实践指南：肝胆癌
J Natl Compr Canc Netw. 2009 Apr;7(4):350-91. doi: 10.6004/jnccn.2009.0027.
3
HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer.HER受体家族：胆囊癌和肝外胆管癌靶向治疗的新候选靶点
Gastrointest Cancer Res. 2007 Nov;1(6):221-7.
4
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.拉帕替尼用于晚期胆管癌和肝细胞癌患者的II期研究。
Cancer Chemother Pharmacol. 2009 Sep;64(4):777-83. doi: 10.1007/s00280-009-0927-7. Epub 2009 Jan 24.
5
Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.基因表达系列分析确定结缔组织生长因子表达为胆囊癌的一种预后生物标志物。
Clin Cancer Res. 2008 May 1;14(9):2631-8. doi: 10.1158/1078-0432.CCR-07-1991.
6
Systemic therapy for biliary tract cancers.胆管癌的全身治疗
Oncologist. 2008 Apr;13(4):415-23. doi: 10.1634/theoncologist.2007-0252.
7
Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.胆道癌中罕见的PIK3CA热点突变。
Genes Chromosomes Cancer. 2008 May;47(5):363-7. doi: 10.1002/gcc.20540.
8
Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas.西妥昔单抗联合吉西他滨-奥沙利铂（GEMOX）用于难治性晚期肝内胆管癌患者。
Oncology. 2007;72(1-2):105-10. doi: 10.1159/000111117. Epub 2007 Nov 15.
9
A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer.不可切除胆管癌化疗生存获益的多中心回顾性分析
Jpn J Clin Oncol. 2007 Nov;37(11):843-51. doi: 10.1093/jjco/hym116. Epub 2007 Oct 17.
10
Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection.偶然发现的胆囊癌中残余病灶的检出率：对再次手术的影响
J Gastrointest Surg. 2007 Nov;11(11):1478-86; discussion 1486-7. doi: 10.1007/s11605-007-0309-6. Epub 2007 Sep 11.
Zotero 插件